- Filed
- Feb 7, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Feb 7, 2024 | 30.01M sh |
| Stockholders Equity | Q2 2024 · Dec 31, 2023 | −$103.49K |
| Stockholders Equity | Q2 2024 · Jun 30, 2023 | −$541.96K |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $3.17M |
| Current Liabilities | Q2 2024 · Jun 30, 2023 | $2.05M |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $3.17M |
| Total Liabilities | Q2 2024 · Jun 30, 2023 | $2.05M |
| Current Assets | Q2 2024 · Dec 31, 2023 | $2.71M |
| Current Assets | Q2 2024 · Jun 30, 2023 | $1.31M |
| Total Assets | Q2 2024 · Dec 31, 2023 | $3.09M |
| Total Assets | Q2 2024 · Jun 30, 2023 | $1.48M |
| Shares Diluted restated | Q2 2024 · Dec 31, 2022 | 30M sh |
| Shares Diluted restated | Q2 2024 · Dec 31, 2022 | 30M sh |
| Capex | Q2 2024 · Dec 31, 2022 | $48.51K |
| Operating Cash Flow | Q2 2024 · Dec 31, 2022 | −$337.71K |
| Eps Diluted restated | Q2 2024 · Dec 31, 2022 | −$0.01 |
| Eps Diluted restated | Q2 2024 · Dec 31, 2022 | −$0.02 |
| Eps Basic restated | Q2 2024 · Dec 31, 2022 | −$0.01 |
| Eps Basic restated | Q2 2024 · Dec 31, 2022 | −$0.02 |
| Sga Expense | Q2 2024 · Dec 31, 2022 | $215.08K |
| Sga Expense | Q2 2024 · Dec 31, 2022 | $790.62K |
| Net Income restated | Q2 2024 · Dec 31, 2022 | −$156.92K |
| Net Income restated | Q2 2024 · Dec 31, 2022 | −$437.57K |
| Operating Income | Q2 2024 · Dec 31, 2022 | −$176.69K |
| Operating Income | Q2 2024 · Dec 31, 2022 | −$492.12K |
| Gross Profit | Q2 2024 · Dec 31, 2022 | $38.39K |
| Gross Profit | Q2 2024 · Dec 31, 2022 | $298.49K |
| Cost Of Revenue | Q2 2024 · Dec 31, 2022 | $25.8K |
| Cost Of Revenue | Q2 2024 · Dec 31, 2022 | $181.26K |
| Revenue | Q2 2024 · Dec 31, 2022 | $64.19K |
| Revenue | Q2 2024 · Dec 31, 2022 | $479.76K |